Compositions and Methods for the Treatment of Cancer Characterized With PCSK9 Expression
Copyright © Targeted News Service 2024
2024-10-29
ALEXANDRIA, Virginia, Oct. 29 -- DUKE UNIVERSITY, Durham, North Carolina has been assigned a patent (No. US 12129284 B2, initially filed June 25, 2019) developed by Chuan-Yuan Li, Durham, North Carolina, and Xinjian Liu, Durham, North Carolina, for "Compositions and methods for the treatment of cancer characterized with PCSK9 expression." . . .